We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$814M
1-Year Est. Return
40.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$323M
AUM Growth
+$78.7M
(+32%)
Cap. Flow
+$70.4M
Cap. Flow
% of AUM
21.81%
Top 10 Holdings %
Top 10 Hldgs %
18.57%
Holding
295
New
49
Increased
141
Reduced
42
Closed
24
Top Buys
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$3.69M |
| 2 |
PayPal
PYPL
|
+$3.53M |
| 3 |
CLGX
Corelogic, Inc.
CLGX
|
+$3.03M |
| 4 |
Verizon
VZ
|
+$2.54M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
+$2.49M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$10.1M |
| 2 |
AbbVie
ABBV
|
+$9.21M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$2.88M |
| 4 |
Comcast
CMCSA
|
+$1.48M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.47M |
Sector Composition
| 1 | Healthcare | 11.9% |
| 2 | Technology | 11.63% |
| 3 | Communication Services | 10.75% |
| 4 | Consumer Discretionary | 9.8% |
| 5 | Financials | 9.31% |
Similar funds
VFG
KCP
AR
CICI
TFM
UAG
PS
BC
Stanley-Laman Group's Q4 2016 Portfolio in Review
As of Q4 2016, Stanley-Laman Group held 295 positions worth $323M, up 32% from $244M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Stanley-Laman Group deployed $70.4M of net new capital in Q4 2016, opening 49 new positions and adding to 141 existing holdings. Its largest new stake was Activision Blizzard: 92,231 shares worth $3.33M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 19% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was AbbVie, an estimated $9.21M trimmed.
- Stanley-Laman Group's largest Q4 2016 buy was Activision Blizzard: 92,231 shares worth $3.33M.
- Stanley-Laman Group added most to Verizon in Q4 2016, an estimated $2.54M increase.
- Stanley-Laman Group's biggest Q4 2016 reduction was AbbVie, cutting an estimated $9.21M.
- Stanley-Laman Group fully exited Gilead Sciences in Q4 2016, selling an estimated $10.1M.
- Stanley-Laman Group's ten largest holdings make up 19% of its $323M portfolio in Q4 2016.
- Stanley-Laman Group opened 49 new positions and closed 24 in Q4 2016.
- Stanley-Laman Group's portfolio value rose 32% quarter-over-quarter to $323M.
Based on Stanley-Laman Group's 13F filing for Q4 2016, filed 6 Feb 2017.